{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:09:09Z","timestamp":1789513749526,"version":"build-2803163510"},"reference-count":44,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.3892\/or.2011.1577","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T07:43:39Z","timestamp":1323157419000},"page":"1219-1226","source":"Crossref","is-referenced-by-count":23,"title":["Valproic acid overcomes hypoxia-induced resistance to apoptosis"],"prefix":"10.3892","volume":"27","author":[{"given":"\u0160IMON","family":"CIPRO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JANA","family":"H\u0158EBA\u010cKOV\u00c1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAN","family":"HRAB\u011aTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JITKA","family":"POLJAKOV\u00c1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOM\u00c1\u0160","family":"ECKSCHLAGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"key":"key20180107213854_b1-or-27-04-1219","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20180107213854_b2-or-27-04-1219","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/ijc.22401","article-title":"Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood","volume":"120","author":"Furchert","year":"2007","journal-title":"Int J Cancer"},{"key":"key20180107213854_b3-or-27-04-1219","doi-asserted-by":"crossref","first-page":"e23127","DOI":"10.1371\/journal.pone.0023127","article-title":"Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation","volume":"6","author":"Mossman","year":"2011","journal-title":"PloS One"},{"key":"key20180107213854_b4-or-27-04-1219","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/138920007780655397","article-title":"Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application","volume":"8","author":"Santini","year":"2007","journal-title":"Curr Drug Metab"},{"key":"key20180107213854_b5-or-27-04-1219","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2119\/2007-00084.Bokelmann","article-title":"Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins","volume":"14","author":"Bokelmann","year":"2007","journal-title":"Mol Med"},{"key":"key20180107213854_b6-or-27-04-1219","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/cdd.2010.58","article-title":"Cracking the death code: apoptosis-related histone modifications","volume":"1","author":"Fullgrabe","year":"2010","journal-title":"Cell Death Differ"},{"key":"key20180107213854_b7-or-27-04-1219","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2478\/v10102-009-0019-x","article-title":"Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells","volume":"2","author":"Hrebackova","year":"2009","journal-title":"Interdiscip Toxicol"},{"key":"key20180107213854_b8-or-27-04-1219","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00001813-199609000-00008","article-title":"Antitumor activity of sodium valproate in cultures of human neuroblastoma cells","volume":"7","author":"Cinatl","year":"1996","journal-title":"Anticancer Drugs"},{"key":"key20180107213854_b9-or-27-04-1219","first-page":"1795","article-title":"Valproic acid and interferon-\u03b1 synergistically inhibit neuroblastoma cell growth in vitro and in vivo","volume":"25","author":"Michaelis","year":"2004","journal-title":"Int J Oncol"},{"key":"key20180107213854_b10-or-27-04-1219","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia - a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107213854_b11-or-27-04-1219","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res"},{"key":"key20180107213854_b12-or-27-04-1219","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1158\/1535-7163.MCT-06-0145","article-title":"Chronic hypoxia promotes hypoxia-inducible factor-1alpha-dependent resistance to etoposide and vincristine in neuroblastoma cells","volume":"5","author":"Hussein","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"key20180107213854_b13-or-27-04-1219","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1748-717X-4-29","article-title":"Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression","volume":"4","author":"Lara","year":"2009","journal-title":"Radiat Oncol"},{"key":"key20180107213854_b14-or-27-04-1219","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00280-006-0224-7","article-title":"Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene","volume":"58","author":"Song","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107213854_b15-or-27-04-1219","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.leu.2404224","article-title":"Hypoxia suppresses BCR\/Abl and selects imatinib-insensitive progenitors within clonal CML populations","volume":"20","author":"Giuntoli","year":"2006","journal-title":"Leukemia"},{"key":"key20180107213854_b16-or-27-04-1219","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00109-006-0133-6","article-title":"Hypoxia-induced genetic instability - a calculated mechanism underlying tumor progression","volume":"85","author":"Huang","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"key20180107213854_b17-or-27-04-1219","first-page":"941","article-title":"Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma","volume":"56","author":"Brizel","year":"1996","journal-title":"Cancer Res"},{"key":"key20180107213854_b18-or-27-04-1219","first-page":"4509","article-title":"Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"Hockel","year":"1996","journal-title":"Cancer Res"},{"key":"key20180107213854_b19-or-27-04-1219","first-page":"4525","article-title":"Hypoxic cervical cancers with low apoptotic index are highly aggressive","volume":"59","author":"Hockel","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107213854_b20-or-27-04-1219","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0076-6879(00)22004-1","article-title":"Detection of apoptosis by annexin V labeling","volume":"322","author":"Bossy-Wetzel","year":"2000","journal-title":"Methods Enzymol"},{"key":"key20180107213854_b21-or-27-04-1219","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"key20180107213854_b22-or-27-04-1219","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.gene.2005.10.038","article-title":"Bid, a BH3-only multi-functional molecule, is at the cross road of life and death","volume":"369","author":"Yin","year":"2006","journal-title":"Gene"},{"key":"key20180107213854_b23-or-27-04-1219","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/sj.onc.1203814","article-title":"Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis","volume":"19","author":"Baek","year":"2000","journal-title":"Oncogene"},{"key":"key20180107213854_b24-or-27-04-1219","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jcb.20683","article-title":"HIF-1alpha has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression","volume":"97","author":"Liu","year":"2006","journal-title":"J Cell Biochem"},{"key":"key20180107213854_b25-or-27-04-1219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emm.2004.1","article-title":"Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions","volume":"36","author":"Lee","year":"2004","journal-title":"Exp Mol Med"},{"key":"key20180107213854_b26-or-27-04-1219","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1152\/jappl.2000.88.4.1474","article-title":"HIF-1: mediator of physiological and pathophysiological responses to hypoxia","volume":"88","author":"Semenza","year":"2000","journal-title":"J Appl Physiol"},{"key":"key20180107213854_b27-or-27-04-1219","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0305-7372(03)00003-3","article-title":"Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies","volume":"29","author":"Shannon","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"key20180107213854_b28-or-27-04-1219","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/emm.2004.32","article-title":"Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells","volume":"36","author":"Um","year":"2004","journal-title":"Exp Mol Med"},{"key":"key20180107213854_b29-or-27-04-1219","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/379088a0","article-title":"Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours","volume":"379","author":"Graeber","year":"1996","journal-title":"Nature"},{"key":"key20180107213854_b30-or-27-04-1219","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1349-7006.2007.00643.x","article-title":"Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer","volume":"99","author":"Liu","year":"2008","journal-title":"Cancer Sci"},{"key":"key20180107213854_b31-or-27-04-1219","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0006-2952(02)01155-3","article-title":"Is HIF-1alpha a pro- or an anti-apoptotic protein?","volume":"64","author":"Piret","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"key20180107213854_b32-or-27-04-1219","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1038\/sj.onc.1204742","article-title":"Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia","volume":"20","author":"Suzuki","year":"2001","journal-title":"Oncogene"},{"key":"key20180107213854_b33-or-27-04-1219","first-page":"647","article-title":"Regulation of the HIF-1\u03b1 stability by histone deacetylases","volume":"17","author":"Kim","year":"2007","journal-title":"Oncol Rep"},{"key":"key20180107213854_b34-or-27-04-1219","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/32925","article-title":"Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha","volume":"392","author":"An","year":"1998","journal-title":"Nature"},{"key":"key20180107213854_b35-or-27-04-1219","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature09141","article-title":"HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase","volume":"465","author":"Sendoel","year":"2010","journal-title":"Nature"},{"key":"key20180107213854_b36-or-27-04-1219","doi-asserted-by":"crossref","first-page":"33","DOI":"10.18632\/aging.100254","article-title":"HIF-1\u03b1 antagonizes p53-mediated apoptosis by triggering HIPK2 degradation","volume":"3","author":"Nardinocchi","year":"2011","journal-title":"Aging"},{"key":"key20180107213854_b37-or-27-04-1219","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1476-4598-9-191","article-title":"Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia","volume":"9","author":"Flamant","year":"2010","journal-title":"Mol Cancer"},{"key":"key20180107213854_b38-or-27-04-1219","doi-asserted-by":"crossref","first-page":"18702","DOI":"10.1074\/jbc.M011774200","article-title":"Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms","volume":"276","author":"Dong","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107213854_b39-or-27-04-1219","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.yexcr.2006.05.018","article-title":"Hypoxia protects HepG2 cells against etoposide-induced apoptosis via a HIF-1-independent pathway","volume":"312","author":"Piret","year":"2006","journal-title":"Exp Cell Res"},{"key":"key20180107213854_b40-or-27-04-1219","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0169-328X(98)00303-9","article-title":"Valproate robustly enhances AP-1 mediated gene expression","volume":"64","author":"Chen","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"key20180107213854_b41-or-27-04-1219","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/138945010790711923","article-title":"Valproic acid in the complex therapy of malignant tumors","volume":"11","author":"Hrebackova","year":"2010","journal-title":"Curr Drug Targets"},{"key":"key20180107213854_b42-or-27-04-1219","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1210\/jc.2004-1355","article-title":"Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells","volume":"90","author":"Catalano","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107213854_b43-or-27-04-1219","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nm1161","article-title":"Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells","volume":"11","author":"Nebbioso","year":"2005","journal-title":"Nat Med"},{"key":"key20180107213854_b44-or-27-04-1219","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-7-55","article-title":"Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells","volume":"7","author":"Muhlethaler-Mottet","year":"2008","journal-title":"Mol Cancer"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2011.1577\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T10:32:16Z","timestamp":1713177136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2011.1577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,6]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,12,6]]},"published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.3892\/or.2011.1577"],"URL":"https:\/\/doi.org\/10.3892\/or.2011.1577","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,6]]}}}